![Alan Bradley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Bradley
Fondateur chez
Kymab Group Ltd.
Profil
Allan Bradley is the founder of Spectral Genomics, Inc., founded in 2000.
Dr. Bradley is the founder of ExpressionEdits Ltd., founded in 2021.
Dr. Bradley is the founder of T-Therapeutics Ltd., founded in 2022, and holds the title Chief Scientific Officer & Director since 2025.
Dr. Bradley is also the founder of Lexicon Pharmaceuticals, Inc.,Kymab Group Ltd...
Dr. Bradley is an Independent Director at Sieger Healthcare Acquisition Corp.
Dr. Bradley is a Professor at the University of Cambridge.
Dr. Bradley was Executive Director at Wellcome Trust Sanger Institute.
Dr. Bradley was Professor at Baylor College of Medicine.
Dr. Bradley completed undergraduate, graduate, and doctorate degrees at the University of Cambridge.
Postes actifs de Alan Bradley
| Sociétés | Poste | Début |
|---|---|---|
Sieger Healthcare Acquisition Corp.
 Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Directeur/Membre du Conseil | - |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Fondateur | - |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Alan Bradley
| Sociétés | Poste | Fin |
|---|---|---|
ExpressionEdits Ltd.
 ExpressionEdits Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that redesigns transgenic instructions by AI-driven platform | Fondateur | - |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| LEXICON PHARMACEUTICALS, INC. | Fondateur | - |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Provides genomic research services | Directeur/Membre du Conseil | - |
Spectral Genomics, Inc.
 Spectral Genomics, Inc. BiotechnologyHealth Technology Develops DNA microarrays and chips used in cloning and genome profiling | Fondateur | - |
Formation de Alan Bradley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spectral Genomics, Inc.
Spectral Genomics, Inc. BiotechnologyHealth Technology Develops DNA microarrays and chips used in cloning and genome profiling | Health Technology |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Provides genomic research services | Health Technology |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
Sieger Healthcare Acquisition Corp.
Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
ExpressionEdits Ltd.
ExpressionEdits Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that redesigns transgenic instructions by AI-driven platform | Commercial Services |
Choisissez Zonebourse 
